A Ki-67 Index to Predict Treatment Response to the Capecitabine/Temozolomide Regimen in Neuroendocrine Neoplasms: A Retrospective Multicenter StudyWei Wang, Jie Chen, Ying Peng et al.|Neuroendocrinology|2020Cited by 30